Signalling pathways involved in paracetamol-induced hepatotoxicity: New insights on the role of protein tyrosine phosphatase 1B

Archives of Physiology and Biochemistry

Volumn 120, Issue 2, 2014, Pages 51-63

  Mobasher, Maysa Ahmed ^a,b   Valverde, Ángela M ^a,b  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Apoptosis; Hepatotoxicity; Necrosis; Oxidative stress; Paracetamol; Protein tyrosine phosphates 1B

Indexed keywords

PARACETAMOL; PROTEIN TYROSINE PHOSPHATASE 1B;

ANIMAL; APOPTOSIS; ARTICLE; DRUG EFFECT; ENZYMOLOGY; HUMAN; LIVER CELL; METABOLISM; SIGNAL TRANSDUCTION;

ACETAMINOPHEN; ANIMALS; APOPTOSIS; HEPATOCYTES; HUMANS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; SIGNAL TRANSDUCTION;

EID: 84910142073     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2014.893365     Document Type: Article

References (152)

1. Aguirre V, Uchida T, Yenush L, Davis R. (2000). White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem, 275:9047-54.
2. Aleksunes LM, Manautou JE. (2007). Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease. Toxicol Path, 35:459-73.
3. Antoine DJ, Williams DP, Kipar A, et al. (2009). High Mobility Group Box-1 protein and Keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo. Toxicol Sci, 112:521-31.
4. Antoine DJ, Jenkins RE, Dear JW, et al. (2012). Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol, 56:1070-9.
5. Aoki H, Kang PM, Hampe J, et al. (2002). Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J Biol Chem, 277:10244-50.
6. Baird L, Llères D, Swift S, Dinkova-Kostova AT. (2013). Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc Natl Acad Sci USA, 110:15259-64.
7. Balsamo J, Leung T, Ernst H, et al. (1996). Regulated binding of PTP1Blike phosphatase to N-cadherin: Control of cadherin-mediated adhesion by dephosphorylation of beta-catenin. J Cell Biol, 134:801-13.
8. Bandyopadhyay D, Kusari A, Kenner KA, et al. (1997). Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin. J Biol Chem, 272: 1639-45.
9. Bechmann LP, Jochum C, Kocabayoglu P, et al. (2010). Cytokeratin 18- based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J Hepatol, 53:639-47.
10. Bessems JG, Vermeulen NP. (2001). Paracetamol (acetaminophen)- induced toxicity: Molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol, 31:55-138.
11. Bloom DA, Jaiswal AK. (2003). Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J Biol Chem, 278:44675-82.
12. Bogoyevitch MA. (2006). The isoform-specific functions of the c-Jun N-terminal Kinases (JNKs): Differences revealed by gene targeting. Bioessays, 28:923-34.
13. Bradham CA, Stachlewitz RF, Gao W, et al. (1997). Reperfusion after liver transplantation in rats differentially activates the mitogenactivated protein kinases. Hepatology, 25:1128-35.
14. Bursch W, Wastl U, Hufnagl K, Schulte-Hermann R. (2005). No increase of apoptosis in regressing mouse liver after withdrawal of growth stimuli or food restriction. Toxicol Sci, 85:507-14.
15. Canbay A, Friedman S, Gores GJ. (2004). Apoptosis: The nexus of liver injury and fibrosis. Hepatology, 39:273-8.
16. Chan JY, Han XL, Kan YW. (1993). Isolation of cDNA encoding the human NF-E2 protein. Proc Natl Acad Sci USA, 90:11366-70.
17. Chan JY, Kwong M, Lu R, et al. (1998). Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J, 17:1779-87.
18. Chan JY, Kwong M. (2000). Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein. Biochim Biophys Acta, 1517:19-26.
19. Chan K, Lu R, Chang JC, Kan YT. (1996). Nrf2, a member of the NF-E2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci USA, 93:13943-8.
20. Chauhan D, Li G, Hideshima T, et al. (2003). JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells. J Biol Chem, 278:17593-6.
21. Chiarugi A, Meli E, Calvani M, et al. (2003). Novel isoquinolinonederived inhibitors of poly (ADP-ribose) polymerase-1: Pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia. J Pharmacol Exp Ther, 305: 943-9.
22. Choi JH, Kim HS, Kim SH, et al. (2006). Phospholipase C gamma1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase-1B. Nat Cell Biol, 8:1389-97.
23. Corcoran GB, Racz WJ, Smith CV, Mitchell JR. (1985). Effects of N-acetylcysteine on acetaminophen covalent binding and hepatic necrosis in mice. J Pharmacol Exp Ther, 232:864-72.
24. Craig DG, Lee P, Pryde EA, et al. (2011). Circulating apoptotic and necrotic cell death markers in patients with acute liver injury. Liver Int, 31:1127-36.
25. Cullinan SB, Zhang D, Hannink M, et al. (2003). Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol, 23:7198-209.
26. Cullinan SB, Gordan JD, Jin J, et al. (2004). The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: Oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol, 24:8477-86.
27. Czaja MJ. (2007). Cell signalling in oxidative stress-induced liver injury. Semin Liver Dis, 27:378-89.
28. Dadke SS, Cotteret SC, Yip ZM, et al. (2007). Regulation of protein tyrosine phosphatase 1B by sumoylation. Nat Cell Biol, 9:80-5.
29. Dahlin DC, Miwa GT, Lu AY, Nelson SD. (1984). N-acetyl-pbenzoquinone imine: A cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA, 81:1327-31.
30. Dhakshinamoorthy S, Jaiswal AK. (2001). Functional characterization and role of INrf2 in antioxidant response element-mediated expression and antioxidant induction of NAD(P)H quinone oxidoreductase1 gene. Oncogene, 20:3906-17.
31. Dixit R, Boelsterli UA. (2007). Healthy animals and animal models of human disease(s) in safety assessment of human pharmaceuticals, including therapeutic antibodies. Drug Discov Today, 12:336-42.
32. Dong H, Haining RL, Thummel KE, et al. (2000). Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen. Drug Metab Dispos, 28:1397-400.
33. Eichhorst ST, Krueger A, Muerkoster S, et al. (2004). Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice. Nat Med, 10:602-9.
34. Enomoto A, Itoh K, Nagayoshi E, et al. (2001). High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci, 59:169-77.
35. Fabregat I, Roncero C, Fernandez M. (2007). Survival and apoptosis: A dysregulated balance in liver cancer. Liver Int, 27:155-62.
36. Filippini M, Bazzani C, Zingarelli S, et al. (2008). Anti-TNF alpha agents in elderly patients with rheumatoid arthritis: A study of a group of 105 over sixty five year old patients. Reumatismo, 60:41-9.
37. Frangioni JV, Oda A, Smith M, et al. (1993). Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase1B (PTP1B) in human platelets. EMBO J, 12:4843-56.
38. Furukawa M, Xiong Y. (2005). BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol Cell Biol, 25:162-71.
39. Geyer R, Wee S, Anderson S, et al. (2003). BTB/POZ domain proteins are putative substrate adaptors for cullin 3 ubiquitin ligases. Mol Cell, 12:783-90.
40. Ghosh A, Sil PC. (2009). Protection of acetaminophen induced mitochondrial dysfunctions and hepatic necrosis via Akt-NF-kappaB pathway: Role of a novel plant protein. Chem Biol Interact, 177: 96-106.
41. Gillette JR, Nelson SD, Mulder GJ, et al. (1981). Formation of chemically reactive metabolites of phenacetin and acetaminophen. Adv Exp Med Biol, 136:931-50.
42. González-Rodr?́guez A, Escribano O, Alba J, et al. (2007). Levels of protein tyrosine phosphatase 1B determine susceptibility to apoptosis in serum-deprived hepatocytes. J Cell Physiol, 212:76-88.
43. Grisham MB. (2004). Reactive oxygen species in immune responses. Free Radic Biol Med, 36:1479-80.
44. Gunawan BK, Liu ZX, Han D, et al. (2006). c-Jun N-terminal kinase plays a major role in murine acetaminophen hepatotoxicity. Gastroenterology, 131:165-78.
45. Gutterman DD, Miura H, Liu Y. (2005). Redox modulation of vascular tone: Focus of potassium channel mechanisms of dilation. Arterioscler Thromb Vasc Biol, 25:671-8.
46. Haj FG, Verveer PJ, Squire A, et al. (2002). Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science, 295:1708-11.
47. Han D, Ybanez MD, Ahmadi S, et al. (2009). Redox regulation of tumor necrosis factor signalling. Antioxid Redox Signal, 11:2245-63.
48. Han D, Shinohara M, Ybanez MD, et al. (2010). Signal transduction pathways involved in drug-induced liver injury. Handb Exp Pharmacol, 196:267-310.
49. Hanawa N, Shinohara M, Saberi B, et al. (2008). Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury. J Biol Chem, 283:13565-77.
50. Haque A, Andersen JN, Salmeen A, et al. (2011). Conformation-sensing antibodies stabilize the oxidized form of PTP1B and inhibit its phosphatase activity. Cell, 147:185-98.
51. Hayes JD, McMahon M. (2009). Nrf2 and KEAP1 mutations: Permanent activation of an adaptive response in cancer. Trends Biochem Sci, 34: 176-88.
52. Henderson NC, Pollock KJ, Frew J, et al. (2007). Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure. Gut, 56:982-90.
53. Hensley K, Robinson KA, Gabbita SP, et al. (2000). Reactive oxygen species, cell signalling, and cell injury. Free Radic Biol Med, 15: 1456-62.
54. Hernandez MV, Sala MG, Balsamo J, et al. (2006). ER-bound PTP1B is targeted to newly forming cell-matrix adhesions. J Cell Sci, 119: 1233-43.
55. Higuchi Y. (2003). Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress. Biochem Pharmacol, 66: 1527-35.
56. Hinson JA, Pohl LR, Monks TJ, et al. (1980). 3-Hydroxyacetaminophen: A microsomal metabolite of acetaminophen. Evidence against an epoxide as the reactive metabolite of acetaminophen. Drug Metab Dispos, 8:289-94.
57. Huang X, Li J, Foster D, Lemanski SL, et al. (2002). Protein kinase Cmediated desmin phosphorylation is related to myofibril disarray in cardiomyopathic hamster heart. Exp Biol Med, 227:1039-46.
58. Huo Y, Qiu WY, Pan Q, et al. (2009). Reactive oxygen species (ROS) are essential mediators in epidermal growth factor (EGF)-stimulated corneal epithelial cell proliferation, adhesion, migration, and wound healing. Exp Eye Res, 89:876-86.
59. Igarashi K, Kataoka K, Itoh K, et al. (1994). Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature, 367:568-72.
60. Ikuta T, Kan YW. (1991). In vivo protein-DNA interactions at the betaglobin gene locus. Proc Natl Acad Sci USA, 88:10188-92.
61. Imai H, Nakagawa Y. (2003). Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic Biol Med, 34:145-69.
62. Itoh K, Chiba T, Takahashi S, et al. (1997). An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun, 236:313-22.
63. Itoh K, Wakabayashi N, Katoh Y, et al. (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev, 13:76-86.
64. Itoh K, Tong KI, Yamamoto M. (2004). Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med, 15:1208-13.
65. Jaeschke H, Bajt ML. (2006). Intracellular signalling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci, 89:31-41.
66. Jain AK, Jaiswal AK. (2007). GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem, 282:16502-10.
67. James LP, Mayeux PR, Hinson JA. (2003). Acetaminophen-induced hepatotoxicity. Drug Metab Dispos, 31:1499-506.
68. Johnson GL, Nakamura K. (2007). The c-jun kinase/stress-activated pathway: Regulation, function and role in human disease. Biochim Biophys Acta, 1773:1341-8.
69. Jollow DJ, Mitchell JR, Potter WZ, et al. (1973). Acetaminopheninduced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther, 187:195-202.
70. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. (1974). Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology, 11:151-69.
71. Kang MI, Kobayashi A, Wakabayashi N, et al. (2004). Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes. Proc Natl Acad Sci USA, 101:2046-51.
72. Kaplowitz N. (2004). Acetaminophen hepatoxicity: What do we know, what don't we know, and what do we do next? Hepatology, 40:23-6.
73. Kaplowitz N. (2005). Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov, 4:489-99.
74. Kaplowitz N, Shinohara M, Liu ZX, Han D. (2008). How to protect against acetaminophen: Don't ask for JUNK. Gastroenterology, 135: 1047-51.
75. Kaspar JW, Niture SK, Jaiswal AK. (2009). Nrf2:INrf2 (Keap1) signalling in oxidative stress. Free Rad Biol Med, 47:1304-9.
76. Katoh Y, Itoh K, Yoshida E, et al. (2001). Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells, 6:857-68.
77. Kobayashi A, Ito E, Toki T, et al. (1999). Molecular cloning and functional characterization of a new Cap'n' collar family transcription factor Nrf3. J Biol Chem, 274:6443-52.
78. Kobayashi A, Kang MI, Okawa H, et al. (2004). Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol, 24:7130-9.
79. Kobayashi A, Kang MI, Watai Y, et al. (2006). Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol, 26:221-9.
80. Kuchay SM, Kim N, Grunz EA, et al. (2007). Double knockouts reveal that protein tyrosine phosphatase 1B is a physiological target of calpain-1 in platelets. Mol Cell Biol, 27:6038-52.
81. Kwak JM, Mori IC, Pei ZM, et al. (2003). NADPH oxidase AtrbohD and AtrbohF genes function in ROS-dependent ABA signalling in Arabidopsis. EMBO J, 22:2623-33.
82. Kwak MK, Itoh K, Yamamoto M, et al. (2001). Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. Mol Med, 7:135-45.
83. Lamb JA, Ventura JJ, Hess P, et al. (2003). J unD mediates survival signalling by the JNK signal transduction pathway. Mol Cell, 11: 1479-89.
84. Larson AM, Polson J, Fontana RJ, et al. (2005). Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology, 42:1364-72.
85. Latchoumycandane C, Goh CW, Ong MM, Boelsterli UA. (2007). Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury. Hepatology, 45: 412-21.
86. Lee WM. (2004). Acetaminophen and the U.S. Acute Liver Failure Study Group: Lowering the risks of hepatic failure. Hepatology, 40: 6-9.
87. Lee WM. (2007). Acetaminophen toxicity: Changing perceptions on a social/medical issue. Hepatology, 46:966-70.
88. Li X, Zhang D, Hannink M, Beamer LJ. (2004). Crystal structure of the Kelch domain of human Keap1. J Biol Chem, 24:54750-8.
89. Liu H, Lo CR, Czaja MJ. (2002). NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology, 35:772-8.
90. McGill MR, Williams CD, Xie Y, et al. (2012). Acetaminophen-induced liver injury in rats and mice: Comparison of protein adducts mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. Toxicol Appl Pharmacol, 264:387-94.
91. McGregor AH, More LJ, Simpson KJ, Harrison DJ. (2003). Liver death and regeneration in paracetamol toxicity. Hum Exp Toxicol, 22:221-7.
92. McMahon M, Thomas N, Itoh K, et al. (2004). Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J Biol Chem, 279:31556-67.
93. Meng TC, Tonks NK. (2003). Analysis of the regulation of protein tyrosine phosphatases in vivo by reversible oxidation. Methods Enzymol, 366:304-18.
94. Mitchell JR, Jollow DJ, Gillette JR, Brodie BB. (1973a). Drug metabolism as a cause of drug toxicity. Drug Metab Dispos, 1:418-23.
95. Mitchell JR, Jollow DJ, Potter WZ, et al. (1973b). Acetaminopheninduced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther, 187:211-17.
96. Mobasher MA, González-Rodr?́guez A, Santamaria B, et al. (2013). Protein tyrosine phosphatase 1B modulates GSK3beta/Nrf2 and IGFIR signalling pathways in acetaminophen-induced hepatotoxicity. Cell Death Dis, 4:1-13.
97. Moi P, Kan YW. (1990). Synergistic enhancement of globin gene expression by activator protein-1-like proteins. Proc Natl Acad Sci USA, 87:9000-4.
98. Moi P, Chan K, Asunis I, et al. (1994). Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci USA, 91:9926-30.
99. Muto A, Hoshino H, Madisen L, et al. (1998). Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 30 enhancer. EMBO J, 17:5734-43.
100. Nakagawa H, Maeda S, Hikiba Y, et al. (2008). Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation. Gastroenterology, 135:1311-21.
101. Nguyen T, Sherratt PJ, Huang HC, et al. (2003). Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J Biol Chem, 278:4536-41.
102. Nioi P, Nguyen T, Sherratt PJ, Pickett CB. (2005). The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation. Mol Cell Biol, 25:10895-906.
103. Niture SK, Jaiswal AK. (2009). Prothymosin-alpha mediates nuclear import of the INrf2/Cul3 Rbx1 complex to degrade nuclear Nrf2. J Biol Chem, 284:13856-68.
104. Niture SK, Jain AK, Shelton PM, Jaiswal AK. (2011). Src subfamily kinases regulate nuclear export and degradation of transcription factor Nrf2 to switch off Nrf2-mediated antioxidant activation of cytoprotective gene expression. J Biol Chem, 286:28821-32.
105. Ockner RK. (2001). Apoptosis and liver diseases: Recent concepts of mechanism and significance. J Gastroenterol Hepatol, 16: 248-60.
106. Ortiz C, Caja L, Bertran E, et al. (2012). Protein-tyrosine Phosphatase 1B (PTP1B) Deficiency confers resistance to transforming growth factor-beta (TGF-beta)-induced suppressor effects in hepatocytes. J Biol Chem, 287:15263-74.
107. Ostapowicz G, Fontana RJ, Schiodt FV, et al. (2002). Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med, 137:947-54.
108. Oyake T, Itoh K, Motohashi H, et al. (1996). Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol Cell Biol, 16:6083-95.
109. Perez M, Haschke B, Donato NJ. (1999). Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: Potential interaction with epidermal growth factor receptor. Oncogene, 18:967-78.
110. Peterson RG, Rumack BH. (1977). Treating acute acetaminophen poisoning with acetylcysteine. JAMA, 237:2406-7.
111. Piperno E, Berssenbruegge DA. (1976). Reversal of experimental paracetamol toxicosis with N-acetylcysteine. Lancet, 2:738-9.
112. Potter DW, Hinson JA. (1987). Mechanisms of acetaminophen oxidation to N-acetyl-P-benzoquinone imine by horseradish peroxidase and cytochrome P-450. J Biol Chem, 262:966-73.
113. Potter WZ, Davis DC, Mitchell JR, et al. (1973). Acetaminopheninduced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther, 187:203-10.
114. Prescott LF. (1977). Iatrogenic complications of drug overdosage and poisoning. Acta Pharmacol Toxicol, 41:2-64.
115. Prescott LF. (1980). Hepatotoxicity of mild analgesics. Br J Clin Pharmacol, 2:373-9.
116. Prescott LF. (1983). Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs, 25:290-14.
117. Rada P, Rojo AI, Chowdhry S, et al. (2011). SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. Mol Cell Biol, 31:1121-33.
118. Rada P, Rojo AI, Evrard-Todeschi N, et al. (2012). Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/b-TrCP axis. Mol Cell Biol, 32:3486-99.
119. Ramachandran R, Kakar S. (2009). Histological patterns in drug-induced liver disease. J Clin Pathol, 62:481-92.
120. Raucy JL, Lasker JM, Lieber CS, Black M. (1989). Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochem Biophys, 271:270-83.
121. Ravichandran LV, Esposito DL, Chen J, Quan MJ. (2001). Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J Biol Chem, 276:3543-9.
122. Reid AB, Kurten RC, McCullough SS, et al. (2005). Mechanisms of acetaminophen-induced hepatotoxicity: Role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes. J Pharmacol Exp Ther, 312:509-16.
123. Rumack BH, Peterson RC, Koch GG, Amara IA. (1981). Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med, 141:380-5.
124. Saberi B, Shinohara M, Ybanez MD, et al. (2008). Regulation of H(2)O(2)-induced necrosis by PKC and AMP-activated kinase signalling in primary cultured hepatocytes. Am J Physiol Cell Physiol, 295:50-63.
125. Salazar M, Rojo AI, Velasco D, et al. (2006). Glycogen synthase kinase- 3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem, 281:14841-51.
126. Sangwan V, Paliouras GN, Cheng A, et al. (2006). Protein-tyrosine phosphatase 1B deficiency protects against Fas-induced hepatic failure. J Biol Chem, 281:221-8.
127. Schattenberg JM, Singh R, Wang Y, et al. (2006). JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology, 43: 163-72.
128. Schulte-Hermann R, Bursch W, Grasl-Kraupp B. (1995). Active cell death (apoptosis) in liver biology and disease. Prog Liver Dis, 13: 1-35.
129. Shelton P, Jaiswal AK. (2013). The transcription factor NF-E2-related factor 2 (Nrf2): A protooncogene. FASEB J, 27:414-23.
130. Shinohara M, Koga T, Okamoto K, et al. (2008). Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell, 132:794-806.
131. Shinohara M, Ybanez MD, Win S, et al. (2010). Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1. J Biol Chem, 285:8244-55.
132. Snawder JE, Roe AL, Benson RW, Roberts DW. (1994). Loss of CYP2E1 and CYP1A2 activity as a function of acetaminophen dose: Relation to toxicity. Biochem Biophys Res Commun, 203:532-9.
133. Stewart D, Killeen E, Naquin R, et al. (2003). Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. J Biol Chem, 278:2396-402.
134. Thames G. (2004). Drug-induced liver injury: What you need to know. Gastroenterol Nurs, 27:31-3.
135. Theruvath TP, Czerny C, Ramshesh VK, et al. (2008). C-Jun N-terminal kinase 2 promotes graft injury via the mitochondrial permeability transition after mouse liver transplantation. Am J Transplant, 8: 1819-28.
136. Thummel KE, Lee CA, Kunze KL, et al. (1993). Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. Biochem Pharmacol, 45:1563-9.
137. Tong KI, Katoh Y, Kusunoki H, et al. (2006a). Keap1 recruits Neh2 through binding to ETGE and DLG motifs: Characterization of the two-site molecular recognition model. Mol Cell Biol, 26:2887-900.
138. Tong KI, Kobayashi A, Katsuoka F, Yamamoto M. (2006b). Two-site substrate recognition model for the Keap1-Mrf2 system: A hinge and latch mechanism. Biol Chem, 387:1311-20.
139. Tonks NK, Diltz CD, Fischer EH. (1988). Purification of proteintyrosine phosphatases from human placenta. J Biol Che, 263:6722-30.
140. Uetrecht J. (2008). Idiosyncratic drug reactions: Past, present, and future. Chem Res Toxicol, 21:84-92.
141. Volkmann X, Ansteatt M, Hadem J, et al. (2008). Caspase activation is associated with spontaneous recovery from acute liver failure. Hepatology, 47:1624-33.
142. Wakabayashi N, Itoh K, Wakabayashi J, et al. (2003). Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet, 35:238-45.
143. Wang Y, Singh R, Lefkowitch JH, et al. (2006). Tumor necrosis factorinduced toxic liver injury results from JNK2-dependent activation of caspase-8 and the mitochondrial death pathway. J Biol Chem, 281: 15258-67.
144. Wang H, Liu K, Geng M, et al. (2013). RXRa inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2. Cancer Res, 73:3097-108.
145. Welch KD, Wen B, Goodlett DR, et al. (2005). Proteomic identification of potential susceptibility factors in drug-induced liver disease. Chem Res Toxicol, 18:924-33.
146. Welch KD, Reilly TP, Bourdi M, et al. (2006). Genomic identification of potential risk factors during acetaminophen-induced liver disease in susceptible and resistant strains of mice. Chem Res Toxicol, 19: 223-33.
147. Weston CR, Davis RJ. (2002). The JNK signal transduction pathway. Current Opin Genet Develop, 12:14-21.
148. Xu ZR, Chen LY, Leung L, et al. (2005). Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc Natl Acad Sci USA, 102:4120-5.
149. Yoshida C, Tokumasu F, Hohmura KI. (1999). Long range interacation of cis-DNA elements mediates by architectural transcription factor Bach1. Genes Cells, 4:643-55.
150. Zhang DD, Lo SC, Sun Z, et al. (2005). Ubiquitination of Keap1, a BTBKelch substrate adaptor protein for Cul3, targets Keap1 for degradation by a proteasome-independent pathway. J Biol Chem, 280: 30091-9.
151. Zhang DD. (2006). Mechanistic studies of the Nrf2-Keap1 signalling pathway. Drug Metab Rev, 38:769-89.
152. Zhou Q, Lam PY, Han D, Cadenas E. (2008). c-Jun N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons. J Neurochem, 104:325-35.